PharmacoGx

PharmacoGx provides integrative analysis of pharmacogenomic datasets to identify biomarkers and characterize drug response for precision medicine.

Key Features:

• Integrative analysis capabilities: Enables integration and harmonization of multiple pharmacogenomic datasets for comparative analyses.
• Standardized data access and analysis: Implements a standardized framework to access, normalize, and analyze dispersed pharmacogenomic data.
• Large-scale dataset comparison: Facilitates comparative analyses across large drug sensitivity resources such as the Genomics of Drug Sensitivity in Cancer (GDSC) and the Cancer Cell Line Encyclopedia (CCLE).

Scientific Applications:

• Biomarker development: Identifies candidate biomarkers predictive of drug response from integrated pharmacogenomic profiles.
• Therapeutic design: Supports investigation of drug response patterns to inform design of therapeutic strategies in precision medicine.
• Connectivity Map analysis: Enables analysis of gene expression changes and connectivity mapping in response to drug treatments.

Methodology:

Provides a cohesive computational framework for integrating diverse pharmacogenomic datasets and conducting meta-analyses to investigate drug efficacy and resistance mechanisms.